Minggui Pan
Impact in
- Molecular Biology top 5%
- Protein Kinase Regulation and GTPase Signaling
- Receptor Mechanisms and Signaling
- Signaling Pathways in Disease
- Bone Metabolism and Diseases
- Melanoma and MAPK Pathways
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Sarcoma Diagnosis and Treatment 16
- Lung Cancer Treatments and Mutations 4
- Oncology 16
- Pancreatic and Hepatic Oncology Research 5
- CAR-T cell therapy research 4
- Vascular Tumors and Angiosarcomas 4
- Co-authors
- Philip A. Stork (2 shared papers)Hong Yao (1 shared paper)Randall D. York (1 shared paper)Mark Vossler (1 shared paper)Feng Chen (1 shared paper)Ying Xiong (1 shared paper)Monte M. Winslow (2 shared papers)Michael W. Starbuck (1 shared paper)
- Journals
- Journal of Clinical Oncology (9 papers)Cancers (4 papers)JCO Oncology Practice (3 papers)Drug Design Development and Therapy (2 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Minggui Pan
55 papers receiving 2.4k citations
Minggui Pan's Hit Papers
Peers
Comparison fields: 5 of 102
- Molecular Biology 1.4k
- Oncology 494
- Cellular and Molecular Neuroscience 350
- Nephrology 101
- Cancer Research 206
Countries citing papers authored by Minggui Pan
This map shows the geographic impact of Minggui Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minggui Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minggui Pan more than expected).
Fields of papers citing papers by Minggui Pan
This network shows the impact of papers produced by Minggui Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minggui Pan. The network helps show where Minggui Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Minggui Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | cAMP Activates MAP Kinase and Elk-1 through a B-Raf- and Rap1-Dependent Pathway Hit paper breakdown → | 1997 | 972 |
| 2 | 2006 | 306 | |
| 3 | 2013 | 155 | |
| 4 | 2010 | 125 | |
| 5 | 2019 | 122 | |
| 6 | 2013 | 61 | |
| 7 | 2016 | 56 | |
| 8 | 2019 | 56 | |
| 9 | 2013 | 51 | |
| 10 | 2019 | 45 | |
| 11 | 2007 | 38 | |
| 12 | 2015 | 34 | |
| 13 | 2019 | 32 | |
| 14 | 2018 | 30 | |
| 15 | 2015 | 30 | |
| 16 | 2019 | 29 | |
| 17 | 2017 | 27 | |
| 18 | 2016 | 23 | |
| 19 | 2013 | 19 | |
| 20 | 2018 | 18 |
About Minggui Pan
Minggui Pan is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Surgery and Cancer Research, having authored 59 papers that have together received 2.4k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (16 papers), Cancer Genomics and Diagnostics (5 papers), Pancreatic and Hepatic Oncology Research (5 papers), CAR-T cell therapy research (4 papers), Vascular Tumors and Angiosarcomas (4 papers), Lung Cancer Treatments and Mutations (4 papers), Retinoids in leukemia and cellular processes (3 papers) and Cardiac tumors and thrombi (3 papers). The work is most often cited by research in Molecular Biology (1.4k citations), Oncology (494 citations), Cellular and Molecular Neuroscience (350 citations), Nephrology (101 citations) and Cancer Research (206 citations). Minggui Pan has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Philip A. Stork, Hong Yao, Randall D. York, Mark Vossler, Feng Chen, Ying Xiong, Monte M. Winslow, Michael W. Starbuck, Elena Gallo and Lei Deng. Their work appears in journals such as Journal of Clinical Oncology, Cancers, JCO Oncology Practice, Drug Design Development and Therapy and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.